Johannesburg, November 2025: Sanofi South Africa is proud to announce it has reached Level 1 B-BBEE status, the top rating in South Africa’s transformation framework and a rare achievement for a global healthcare company. The achievement underscores the role of global companies in driving local empowerment and healthcare access and demonstrates the potential support that multinational pharmaceuticals companies can provide in strengthening South Africa’s healthcare system.
Level 1 status recognises performance in all five B-BBEE pillars: ownership, management control, skills, supplier growth, and socio-economic development. For partners, it brings concrete benefits, including 135% procurement recognition to boost their own scorecards.
Developing people and skills
Sanofi places people at the centre of its transformation efforts. The company runs programmes for graduates, persons with disabilities, and young people through the Youth Employment Service, while also investing in management development to support career growth.
“We encourage employees to join leadership programmes that build a pipeline of diverse future leaders,” says Prudence Selani, Head of External Affairs, Sanofi South Africa. “Outside the company, Sanofi has provided interest-free loans and grants to help small businesses expand and create jobs.”
Sanofi goes beyond the B-BBEE compliance, working towards meaningful and lasting results. By the end of 2025, all Sanofi workplaces and digital platforms will be fully accessible, ensuring all employees, including those who are differently abled, can thrive. This includes new accessibility standards, assistive technology, and barrier-free workplace design through the WorkX 2.0 and Digital Accessibility standards, which guarantee full access for people with disabilities, including assistive software where needed.
Gender balance and leadership
Globally, Sanofi is ranked among the Top 25 companies for gender equality and has set clear targets for female leadership. Women already make up 50 % of the workforce, 45 % of senior leaders, and 42 % of executives. By 2025, the goal is for women to hold half of senior leadership roles and at least 40 % of executive positions.
In South Africa, this aligns with the national transformation agenda, where advancing black women into leadership is a key priority. Through targeted development and succession planning, Sanofi is increasing representation of black women in senior decision-making roles. The company also supports families through a global gender-neutral parental leave policy that gives all new parents 14 weeks of paid leave, regardless of gender or sexual orientation.
Supplier development
Expanding opportunities for black-owned and diverse suppliers is one of the biggest challenges in South Africa’s healthcare industry. Sanofi is addressing this by growing local partnerships and strengthening supply chains that support both healthcare resilience and inclusive growth.
Globally, the company has pledged to spend more than €1.5 billion with small and diverse suppliers by 2025. South Africa is already the third largest contributor to that target, showing how local progress can influence global impact.
A key example is Sanofi’s partnership with Biovac, which has expanded local vaccine manufacturing capacity and demonstrated how supplier development can drive industrial capability as well as positive public health outcomes.
“Supplier diversity is not about meeting quotas; it’s about building sustainable capability within the local economy,” says Selani. “When we strengthen local suppliers, we build a stronger healthcare system that serves South Africans for generations to come.”
Community programmes
Inequitable access to healthcare is another of South Africa’s most persistent challenges. Investing in initiatives that improve access to treatment, raise awareness of rare diseases, and support vulnerable groups across the country are key to closing these gaps.
One of the Sanofi’s largest global efforts, the €50 million A Million Conversations initiative, gives marginalised communities a platform to voice concerns and rebuild trust in healthcare. In South Africa, this commitment translates into community projects that extend treatment to more people, strengthen diagnosis and screening, and expand opportunities for healthcare education and awareness.
“You can’t transform healthcare without trust,” says Selani. “That means listening to communities, understanding their realities, and working alongside health professionals and patient groups to make care accessible where it’s needed most.”
Through collaboration with health care professionals, patients, and advocacy organisations, Sanofi aims to help build a healthcare system that is more inclusive, responsive, and trusted by all who depend on it.
“Our Level 1 B-BBEE rating is a springboard for deeper change. We plan to expand clinical research in South Africa, bring more diverse patient groups into trials, and to step up support for black-owned suppliers so they can play a bigger role in the healthcare value chain. We also want to widen access to treatments for rare diseases and immunology, areas where many patients still struggle to get the care they need,” says Selani.
